找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Chronic Viral Hepatitis; Diagnosis and Therap Raymond S. Koff,George Y. Wu Book 20021st edition Springer Science+Business Media New York 20

[復(fù)制鏈接]
樓主: 哄笑
51#
發(fā)表于 2025-3-30 08:12:34 | 只看該作者
52#
發(fā)表于 2025-3-30 14:45:50 | 只看該作者
Hepatitis C and HIV Co-Infection,eaths among people with acquired immune deficiency syndrome (AIDS) declined for the first time in 1996, after the institution of this therapeutic approach. As the life expectancy of HIV-infected patients increases, greater attention will need to be focused on the recognition and management of potent
53#
發(fā)表于 2025-3-30 20:24:40 | 只看該作者
54#
發(fā)表于 2025-3-30 21:58:21 | 只看該作者
55#
發(fā)表于 2025-3-31 01:13:55 | 只看該作者
Treatment of Chronic Hepatitis C Infection,ubclinical, yet there is a high rate of chronicity after infection. As many as 55–85% of individuals who contract HCV infection will develop chronic infection and hepatitis. Of these, at least 20% will progress to cirrhosis after a 10–30 yr period, and are at risk to develop hepatocelluplar carcinom
56#
發(fā)表于 2025-3-31 06:49:03 | 只看該作者
Treatment of Chronic Viral Hepatitis in Patients with Autoimmune Diseases,s associated with hepatitis C . and, to a lesser extent, hepatitis B .; many of these conditions are mediated through autoimmune mechanisms. Shortly after the release of interferon α-2b (IFN-α2b) for the treatment of these viral infections came reports of autoimmune disorders that were either caused
57#
發(fā)表于 2025-3-31 11:07:55 | 只看該作者
Developing Therapeutic Plans for Patients with Chronic Hepatitis B or C,patient with chronic viral hepatitis involves taking care of the entire patient, anticipating the needs and potential problems for each patient, and educating the patient regarding their disease and its management. Developing the therapeutic plan and initiating treatment for the patient with chronic
58#
發(fā)表于 2025-3-31 16:42:57 | 只看該作者
Supporting the Patient with Chronic Hepatitis During Treatment,ific problem with therapy, but in addition the therapy itself is complex, and is associated with a multitude of side effects. This chapter examines strategies for the management of side effects in patients treated with both interferon (IFN) and IFN—ribavirin combination therapy. In the clinical tria
59#
發(fā)表于 2025-3-31 18:43:09 | 只看該作者
Complementary and Alternative Treatment of Liver Disease,the past decade, the proportion of Americans who report using alternative or complementary therapies has grown from 34 to 42%. During that interval, the projected number of total visits to alternative practitioners increased by 47%, from 427 million visits/yr in 1991 to 629 million visits/yr in 1997
60#
發(fā)表于 2025-4-1 00:18:59 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 16:50
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
靖远县| 江山市| 保定市| 湖州市| 河北省| 渭源县| 伊金霍洛旗| 山西省| 商水县| 天镇县| 长武县| 蚌埠市| 辽宁省| 永嘉县| 五常市| 昌平区| 威信县| 如皋市| 建昌县| 新竹市| 河南省| 清水河县| 囊谦县| 许昌县| 澳门| 大荔县| 杨浦区| 重庆市| 阿荣旗| 桦川县| 南丹县| 尼玛县| 陵水| 定兴县| 葵青区| 裕民县| 台南县| 大理市| 南丹县| 讷河市| 富宁县|